Mate1 Substrates + CapmatinibModerate
Coadministration may increase MATE1 substrate exposure, which may increase adverse reactions. Decrease substrate dosage if coadministration unavoidable and minimal concentration changes may lead to serious reactions.
Source: NLP:capmatinib